Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Cytochrome P450c17 catalyzes 17 alpha-hydroxylation needed for cortisol synthesis and 17,20 lyase activity needed to produce sex steroids. Serine phosphorylation of P450c17 specifically increases 17,20 lyase activity, but the physiological factors regulating this effect remain unknown. Treating human adrenal NCI-H295A cells with the phosphatase inhibitors okadaic acid, fostriecin, and cantharidin increased 17,20 lyase activity, suggesting involvement of protein phosphatase 2A (PP2A) or 4 (PP4). PP2A but not PP4 inhibited 17,20 lyase activity in microsomes from cultured cells, but neither affected 17 alpha-hydroxylation. Inhibition of 17,20 lyase activity by PP2A was concentration-dependent, could be inhibited by okadaic acid, and was restored by endogenous protein kinases. PP2A but not PP4 coimmunoprecipitated with P450c17, and suppression of PP2A by small interfering RNA increased 17,20 lyase activity. Phosphoprotein SET found in adrenals inhibited PP2A, but not PP4, and fostered 17,20 lyase activity. The identification of PP2A and SET as post-translational regulators of androgen biosynthesis suggests potential additional mechanisms contributing to adrenarche and hyperandrogenic disorders such as polycystic ovary syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 17,20-lyase activity is also favored by the phosphorylation of serine residues on P450c17 by a cAMP-dependent protein kinase (287-290).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [288]
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,524
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,387
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Analysis of gene function in somatic mammalian cells using small interfering RNAs
Elbashir, S. (2002) · Methods · doi:10.1016/s1046-2023(02)00023-3 · Cited by 1,095
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism
Haystead, T. A. J., Sim, A. T. R., Carling, D., Honnor, R. C., Tsukitani, Y., Cohen, P., & Hardie, D. G. (1989) · Nature · doi:10.1038/337078a0 · Cited by 842
Regulation of protein kinase cascades by protein phosphatase 2A
Millward, T. A., Zolnierowicz, S., & Hemmings, B. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01375-4 · Cited by 793
Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation
Chen, J., Martin, B. L., & Brautigan, D. L. (1992) · Science · doi:10.1126/science.1325671 · Cited by 601
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationGazdar, A. F., Oie, H. K., Shackleton, C. H. L., Chen, T. R., Triche, T. J., Myers, C. E., Chrousos, G. P., Brennan, M. F., Stein, C. A., & Rocca, R. V. L. (1990) · PubMed · Cited by 523
Research works printed but not linked: 7
- Ibañez, 1993, J. Clin. Endocrinol. Metab., 76, 1599
- Oppenheimer, 1995, J. Clin. Endocrinol. Metab., 80, 614
- Picado-Leonard, 1987, DNA (New York), 6, 439
- Rodriguez, 1997, J. Clin. Endocrinol. Metab., 82, 365
- Gazdar, 1990, Cancer Res., 50, 5488
- Staels, 1993, Mol. Endocrinol., 7, 423
- Kim, 1994, Am. J. Physiol., 266, F155
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationRegulation of oocyte maturation in fish
Nagahama, Y., & Yamashita, M. (2008) · Development, Growth & Differentiation · doi:10.1111/j.1440-169x.2008.01019.x · Cited by 890
“…elevation of 17,20-lyase activity is brought about by a cyclic AMP (cAMP)dependent protein kinase (also known as protein kinase A) through serine/threonine phosphorylation (Zhang et al. 1995; Pandey et al. 2003), while dephosphorylation leaves alone the 17a-hydroxylase activity for P450c17.”
γ-H2AX Dephosphorylation by Protein Phosphatase 2A Facilitates DNA Double-Strand Break Repair
Chowdhury, D., Keogh, M.-C., Ishii, H., Peterson, C. L., Buratowski, S., & Lieberman, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.003 · Cited by 551
Wang, R.-S., Yeh, S., Tzeng, C.-R., & Chang, C. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0025 · Cited by 465
Cell‐penetrating peptides: from molecular mechanisms to therapeutics
Morris, M. C., Deshayes, S., Heitz, F., & Divita, G. (2008) · Biology of the Cell · doi:10.1042/bc20070116 · Cited by 361
“, 2005) and pancreatic cells (Pratt and Kinch, 2002; Pandey et al., 2003).”
BackgroundHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
“1998; Auchus and Miller 1999; Pandey et al. 2003).”
BackgroundSelf-citationMinireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Self-citationAdrenarche—physiology, biochemistry and human disease
Auchus, R. J., & Rainey, W. E. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01858.x · Cited by 296
“Although the kinase(s) responsible for CYP17 phosphorylation have not been identified, recent evidence suggests that protein phosphatase 2A (PP2A) inhibits 17,20- lyase activity by dephosphorylating CYP17 (Pandey et al ., 2003).”
BackgroundPolycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
NADPH P450 oxidoreductase: Structure, function, and pathology of diseases
Pandey, A. V., & Flück, C. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.010 · Cited by 279
Self-citationWood, J. R., Nelson, V. L., Ho, C., Jansen, E., Wang, C. Y., Urbanek, M., McAllister, J. M., Mosselman, S., & Strauss, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300688200 · Cited by 260
A PP4-Phosphatase Complex Dephosphorylates γ-H2AX Generated during DNA Replication
Chowdhury, D., Xu, X., Zhong, X., Ahmed, F., Zhong, J., Liao, J., Dykxhoorn, D. M., Weinstock, D. M., Pfeifer, G. P., & Lieberman, J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.016 · Cited by 247
“To investigate a possible role of PP4C in regulating g-H2AX, small interfering RNAs (siRNA) were designed to downregulate PP4C expression specifically without altering expression of the related PP2A family members (Pandey et al., 2003).”
Steroidogenesis: Unanswered Questions
Miller, W. L. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.09.002 · Cited by 226
Self-citationHuang, N., Agrawal, V., Giacomini, K. M., & Miller, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711621105 · Cited by 198
Self-citationA non-covalent peptide-based strategy for protein and peptide nucleic acid transduction
Gros, E., Deshayes, S., Morris, M. C., Aldrian-Herrada, G., Depollier, J., Heitz, F., & Divita, G. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.006 · Cited by 189
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy
Deshayes, S., Morris, M., Heitz, F., & Divita, G. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.005 · Cited by 185
The Rise in Adrenal Androgen Biosynthesis: Adrenarche
Havelock, J. C., Auchus, R. J., & Rainey, W. E. (2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-861550 · Cited by 178
Flück, C. E., Miller, W. L., & Auchus, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030143 · Cited by 173
“Finally, the 17, 20-lyase activity of P450c17 is strongly influenced by serine/threonine phosphorylation (29, 30).”
BackgroundSelf-citationRegulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17
Pandey, A. V., & Miller, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414673200 · Cited by 165
Self-citationLee, D.-H., Pan, Y., Kanner, S., Sung, P., Borowiec, J. A., & Chowdhury, D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1769 · Cited by 156
“The PP4, PP2AC and PP6C siRNAs were described previousl”
Normal and Premature Adrenarche
Rosenfield, R. L. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab009 · Cited by 188
COMORBIDITY OF INTERSTITIAL CYSTITIS WITH OTHER UNEXPLAINED CLINICAL CONDITIONS
TONY BUFFINGTON, C. A. (2004) · Journal of Urology · doi:10.1097/01.ju.0000137953.49304.6c · Cited by 154
A shift in steroidogenesis occurring in ovarian follicles prior to oocyte maturation
Senthilkumaran, B., Yoshikuni, M., & Nagahama, Y. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.012 · Cited by 170
The syndrome of 17,20 lyase deficiency
Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2161 · Cited by 143
Self-citationBremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 151
Self-citationAndrogen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127
“also increases 17,20 lyase activity [82–84], but the kinase has not been identified [85], hence its role in adrenarche remains uncertain.”
BackgroundSelf-citationFlück, C. E., & Miller, W. L. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0342 · Cited by 127
Self-citationIsolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
Nowak, S. J., Pai, C.-Y., & Corces, V. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6129-6138.2003 · Cited by 103
“Given the described roles of SET as an in vivo inhibitor of PP2A activity (21, 29, 33), we were particularly interested to determine if SET can inhibit PP2A-mediated dephosphorylation of Ser10-phosphorylated histone H3 in our previously described in vitro assay.”
BackgroundHuman ovarian theca cells in culture
Wickenheisser, J. K., Nelson-DeGrave, V. L., & McAllister, J. M. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.01.003 · Cited by 112
Diao, F., Xu, M., Hu, Y., Li, J., Xu, Z., Lin, M., Wang, L., Zhou, Y., Zhou, Z., Liu, J., et al. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330059 · Cited by 101
“The serine phosphoprotein SET inhibits PP2A specifically and fosters 17,20-lyase activity ( Pandey & Synthia 2003 ).”
BackgroundHershkovitz, E., Parvari, R., Wudy, S. A., Hartmann, M. F., Gomes, L. G., Loewental, N., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0051 · Cited by 95
Self-citationInhibition of Protein Phosphatase 2A Activity by PI3Kγ Regulates β-Adrenergic Receptor Function
Vasudevan, N. T., Mohan, M. L., Gupta, M. K., Hussain, A. K., & Prasad, S. V. N. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.025 · Cited by 98
“The mechanism by which I2PP2A inhibits PP2A is unknown and is speculated that phosphorylation of I2PP2A may lead to enhanced binding to PP2A (Pandey et al., 2003).”
Clinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Self-citationThe effect of cantharidins on leukemic stem cells
Dorn, D. C., Kou, C. A., Png, K. J., & Moore, M. A. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.24157 · Cited by 75
Carujo, S., Estanyol, J. M., Ejarque, A., Agell, N., Bachs, O., & Pujol, M. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209433 · Cited by 80
“It has been identified as a potent inhibitor of protein phosphatase 2A (Li et al., 1996; Adler et al., 1997; Pandey et al., 2003) and as a regulator of DNA replication, chromatin remodeling and gene transcription (Matsumoto et al., 1993; Okuwaki and Nagata, 1998; Shikama et al., 2000; Seo et al.,…”
BackgroundApproach to the Girl with Early Onset of Pubic Hair
Oberfield, S. E., Sopher, A. B., & Gerken, A. T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0225 · Cited by 73
“Finally, the 17,20-lyase activity of CYP17 is enhanced by phosphorylation of serine and threonine residues by a cAMP-dependent protein kinase (38) and decreased by dephosphorylation via protein phosphatase 2A (39).”
BackgroundBioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway
Castaño, P. R., Parween, S., & Pandey, A. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184606 · Cited by 72
“Steroid metabolism by NCI-H295R cells has been studied in our laboratory for many years and culture conditions and passage numbers (kept below 30) adhered to previously established protocols [40,41,55,56,89,90].”
MethodSelf-citationTee, M. K., & Miller, W. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.460048 · Cited by 69
Self-citationLau, Y. C., Lau, H. W., & Kömüves, L. G. (2003) · Cytogenetic and Genome Research · doi:10.1159/000074345 · Cited by 67
“Some members of this protein family are involved in either regulating or modulating cell cycle progression (Altman and Kellogg, 1997; Shin et al., 1999; Chai et al., 2001; Canela et al., 2003; Pandey et al., 2003).”
BackgroundNaffin-Olivos, J. L., & Auchus, R. J. (2006) · Biochemistry · doi:10.1021/bi051623y · Cited by 66
Nonhuman primates as models for human adrenal androgen production: Function and dysfunction
Abbott, D. H., & Bird, I. M. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9099-8 · Cited by 61
“, insufficient time to alter expression levels of CYP17) can enhance lyase activity relative to hydroxylase activity [18, 62, 92].”
BackgroundMalíková, J., Brixius‐Anderko, S., Udhane, S. S., Parween, S., Dick, B., Bernhardt, R., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.09.007 · Cited by 66
Self-citationSalvador, J. A. R., Pinto, R. M. A., & Silvestre, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.006 · Cited by 82
“b5) [101–104], the phosphorylation f serine/threonine residues [101,105–107], and single amino acid utations [108–111].”
BackgroundSamandari, E., Kempná, P., Nuoffer, J., Hofer, G., Mullis, P. E., & Flück, C. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0166 · Cited by 67
“In addition, there is experimental evidence that enhanced expression of b5 together with abundance in POR as well as phosphorylation of P450c17 lead to an increase in 17,20 lyase activity (Lin et al. 1993, Zhang et al. 1995, Pandey et al. 2003, Pandey & Miller 2005).”
BackgroundP450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57
Self-citationTee, M. K., Dong, Q., & Miller, W. L. (2008) · Endocrinology · doi:10.1210/en.2007-1527 · Cited by 55
“NCI-H295 cells, derived from a human adrenocortical carcinoma (44), express P450c17, catalyze 17 -hydroxylase and 17,20 lyase activities (45, 46), and can phosphorylate P450c17 in a fashion that maximizes 17,20 lyase activity (29, 51).”
BackgroundSelf-citationFlück, C. E., Nicolo, C., & Pandey, A. V. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00520.x · Cited by 55
Self-citationGenetic variation in human P450 oxidoreductase
Miller, W. L., Huang, N., Agrawal, V., & Giacomini, K. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.017 · Cited by 54
“…Endocrinology 300 (2009) 180–184 a o P a 3 s e i i “ b ( e w e T ( t i n f l b r t i m E a J A a b w d m w h g 5 t C f 1 o t m f a n p 3 d a b c r i D D “ p a o m h c e a i s a a t o t 1 B a P o m 82 W.L. Miller et al. / Molecular and Ce nd Miller, 2005; Zhang et al., 1995; Pandey et al., 2003).”
Self-citationLundqvist, J., Norlin, M., & Wikvall, K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.009 · Cited by 61
Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
Miller, W. L. (2005) · Medical Principles and Practice · doi:10.1159/000086185 · Cited by 62
“This phosphorylation is rapidly induced by cAMP, occurs on serine and threonine but not on tyrosine residues, and increases the 17,20 lyase activity of P450c17. Conversely, dephosphorylation of microsomes containing P450c17 ablates 17,20 lyase activity without reducing 17α-hydroxylase activity and without affecting st…”
BackgroundSelf-citationInterleukins 1α and 1β as regulators of steroidogenesis in human NCI-H295R adrenocortical cells
Tkachenko, I. V., Jääskeläinen, T., Jääskeläinen, J., Palvimo, J. J., & Voutilainen, R. (2011) · Steroids · doi:10.1016/j.steroids.2011.04.018 · Cited by 52
The post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“Treating NCI-H295A cells with the phosphatase inhibitors okadaic acid, fostriecin or cantharidin increased 17,20-lyase activity fourfold, suggesting that protein phosphatases 2A (PP2A) and/or PP4 might be involved (Pandey et al., 2003).”
BackgroundSelf-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Self-citationRestoration of mutant cytochrome P450 reductase activity by external flavin
Nicolo, C., Flück, C. E., Mullis, P. E., & Pandey, A. V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.024 · Cited by 50
Self-citationKöhler, A., Demir, Ü., Kickstein, E., Krauß, S., Aigner, J., Aranda-Orgillés, B., Karagiannidis, A. I., Achmüller, C., Bu, H., Wunderlich, A., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-146 · Cited by 51
“Moreover, PP2A is the principal phosphatase down-regulating cytochrome P450c17 and 17,20 lyase (CYP17A1) activity, resulting in decreased levels of androgens [11].”
BackgroundFernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 49
“coli expression system and purified for enzyme kinetic assays [15,17,18,62].”
MethodSelf-citationAndrogens as double-edged swords: Induction and suppression of follicular development
Pan, J., Zhang, J., Ke, Z.-H., Wang, F., Barry, J. A., Hardiman, P., & Qu, F. (2015) · HORMONES · doi:10.14310/horm.2002.1580 · Cited by 45
Vuocolo, S., Purev, E., Zhang, D., Bartek, J., Hansen, K., Soprano, D. R., & Soprano, K. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302715200 · Cited by 43
Huang, N., Dardis, A., & Miller, W. L. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0411 · Cited by 42
Self-citationImpact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase
Flück, C. E., & Pandey, A. V. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.031 · Cited by 43
Self-citationP450 Enzymes in Steroid Processing
Auchus, R. J., & Miller, W. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_12 · Cited by 44
Self-citationPandey, A. V., Flück, C. E., Huang, N., Tajima, T., Fujieda, K., & Miller, W. L. (2004) · Endocrine Research · doi:10.1081/erc-200044134 · Cited by 39
Self-citationSteroid 17α-Hydroxylase Deficiency—Not Rare Everywhere
Miller, W. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031770 · Cited by 39
Self-citationExploring the Chemical Features and Biomedical Relevance of Cell-Penetrating Peptides
Moreno‐Vargas, L. M., & Prada‐Gracia, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010059 · Cited by 52
Adrenal androgens, adrenarche, and zona reticularis: A human affair?
Dumontet, T., & Martinez, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111239 · Cited by 44
Update on Adrenarche—Still a Mystery
Augsburger, P., Liimatta, J., & Flück, C. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae008 · Cited by 48
Heterogeneous nuclear ribonucleoprotein A2 is a SET-binding protein and a PP2A inhibitor
Vera, J., Jaumot, M., Estanyol, J. M., Brun, S., Agell, N., & Bachs, O. (2005) · Oncogene · doi:10.1038/sj.onc.1209050 · Cited by 41
“Specifically, it has been shown that SET modulates the effect of PP2A on dephosphorylating the cytochrome P450c17 and regulating its 17, 20 lyase activity involved in the sex steroids production (Pandey et al., 2003).”
BackgroundKempná, P., Hirsch, A., Hofer, G., Mullis, P. E., & Flück, C. E. (2010) · Endocrinology · doi:10.1210/en.2010-0093 · Cited by 36
“Protein phosphatase 2A is described to dephosphorylate and inactivate P450c17 (11); however, the responsible kinase(s) remain(s) elusive.”
BackgroundPattison, J. C., Abbott, D. H., Wendy Saltzman, A., Nguyen, A. D., Henderson, G. L., Jing, H., Pryce, C. R., Allen, A. J., Conley, A. J., & Bird, I. M. (2004) · Endocrinology · doi:10.1210/en.2004-0689 · Cited by 33
“mechanism such as P450c17 phosphorylation (31).”
Complex assembly on the human CYP17 promoter
Sewer, M. B., & Jagarlapudi, S. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.006 · Cited by 31
Hayashi, T., & Harada, N. (2014) · FEBS Journal · doi:10.1111/febs.13021 · Cited by 35
Wang, Y.-H., Tee, M. K., & Miller, W. L. (2010) · Endocrinology · doi:10.1210/en.2009-1247 · Cited by 31
“Subsequent work showed counterbalancing dephosphorylation by protein phosphatase 2A, which, in turn, was regulated by phosphoprotein SET (8).”
BackgroundSelf-citationEffect of Essential Oil Components on the Activity of Steroidogenic Cytochrome P450
Sharma, K., Lanzilotto, A., Yakubu, J., Therkelsen, S., Voegel, C. D., du Toit, T., Jørgensen, F. S., & Pandey, A. V. (2024) · Biomolecules · doi:10.3390/biom14020203 · Cited by 42
“To determine CYP17A1 hydroxylase activity, cells were treated with the [ 14 C]-Progesterone at a concentration of 10,000 cpm/1 µ M per well [22–24 , 54].”
MethodSelf-citationP450 Oxidoreductase Deficiency: A New Disorder of Steroidogenesis
Miller, W. L., Huang, N., Pandey, A. V., Flück, C. E., & Agrawal, V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1336.012 · Cited by 37
Self-citationModeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.001 · Cited by 31
Self-citationKempná, P., Marti, N., Udhane, S., & Flück, C. E. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.015 · Cited by 29
Güran, T., Yeşil, G., Turan, S., Atay, Z., Bozkurtlar, E. B., Aghayev, A., Gul, S., Tınay, İ., Aru, B., Arslan, S., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0067 · Cited by 30
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Self-citationInsights into Interactions of Human Cytochrome P450 17A1: A Review
Singh, H., Kumar, R., Mazumder, A., Salahuddin, S., Mazumder, R., & Abdullah, M. M. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220401093833 · Cited by 37
Cancer-Targeting Applications of Cell-Penetrating Peptides
Moreno‐Vargas, L. M., & Prada‐Gracia, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010002 · Cited by 31
Proteomic analysis of SET‐binding proteins
Vera, J., Estanyol, J. M., Canela-Canela, N., Llorens, F., Agell, N., Itarte, E., Bachs, O., & Jaumot, M. (2007) · PROTEOMICS · doi:10.1002/pmic.200600458 · Cited by 27
Expression of P450c17 in the Human Fetal Nervous System
Schonemann, M. D., Muench, M. O., Tee, M. K., Miller, W. L., & Mellon, S. H. (2012) · Endocrinology · doi:10.1210/en.2011-1545 · Cited by 28
Self-citationSteroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Self-citationTrbovich, A. M., Martinelle, N., O’Neill, F. H., Pearson, E. J., Donahoe, P. K., Sluss, P. M., & Teixeira, J. M. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.07.002 · Cited by 31
Yang, F., Jaitly, N., Jayachandran, H., Luo, Q., Monroe, M. E., Du, X., Gritsenko, M. A., Zhang, R., Anderson, D. J., Purvine, S. O., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070068e · Cited by 26
Mukhopadhyay, A., Tabanor, K., Chaguturu, R., & Aldrich, J. V. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25943 · Cited by 27
Jiang, S., Xu, S., Chen, H., Liu, X., Tang, Z., Cui, Y., & Liu, J. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.010 · Cited by 24
Inhibition of Src tyrosine kinase stimulates adrenal androgen production
Sirianni, R., Carr, B., Andò, S., & Rainey, W. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300287 · Cited by 23
“Pandey et al. (2003) showed that protein phosphatase 2a is able to dephosphorylate CYP17 and decrease the 17,20 lyase activity of this enzyme, which would also decrease production of DHEA.”
BackgroundSET protein up-regulated testosterone production in the cultured preantral follicles
Xu, B., Gao, L., Cui, Y., Gao, L., Dai, X., Li, M., Zhang, Y., Ma, X., Diao, F., & Liu, J. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-9 · Cited by 22
“showed that, in NCI-H295A cells, SET can foster 17, 20 lyase activity of P450c17 by inhibiting the dephosphorylation action of PP2A on P450c17 [18], because the phosphorylation of P450c17 on serine and threonine residues increases its17, 20 lyase activity through as-yet-unidentified mechanisms, which may involve in in…”
BackgroundInfluentialPatt, M., Beck, K. R., Marco, T. D., Jäger, M.-C., González‐Ruiz, V., Boccard, J., Rudaz, S. L., Hartmann, R. W., Salah, M., van Koppen, C. J., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113781 · Cited by 28
Udhane, S. S., & Flück, C. E. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.10.010 · Cited by 27
Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy
Miller, W. L., Pandey, A. V., & Flück, C. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae815 · Cited by 17
Self-citationGusmano, C., Cannarella, R., Crafa, A., Barbagallo, F., Vignera, S. L., Condorelli, R. A., & Calogero, A. E. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01849-9 · Cited by 21
Vitamin D as a regulator of steroidogenic enzymes
Lundqvist, J. (2014) · F1000Research · doi:10.12688/f1000research.4714.1 · Cited by 21
SET/PP2A system regulates androgen production in ovarian follicles in vitro
Gao, L., Liu, X., Xu, B., Jiang, S., Cui, Y., & Liu, J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.012 · Cited by 15
“Indeed, in NCI-H295A cells which are deprived from human adrenocortical carcinoma it is found that PP2A inhibites the dephosphorylation of P450c17 and increased its 17,20-lyase activity (Pandey et al., 2003a).”
BackgroundResultInfluentialBíró, J., Farkas, I., Domoki, M., Ötvös, K., Bottka, S., Dombrádi, V., & Fehér, A. (2012) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2011.12.010 · Cited by 15
“The animal homologues of the NRP1 protein act in vitro and in vivo as protein phosphatase 2A (PP2A) inhibitors [8,12,20,21].”
BackgroundLo, S. L., & Wang, S. (2010) · Macromolecular Rapid Communications · doi:10.1002/marc.200900934 · Cited by 15
A Three-Phase Algorithm for Computer Aided siRNA Design
Zhou, H., Zeng, X., Wang, Y., & Seyfarth, B. R. (2006) · Informatica · doi:10.31449/inf.v30i3.103 · Cited by 16
Translin Coactivates Steroidogenic Factor-1-Stimulated Transcription
Mellon, S. H., Bair, S. R., Depoix, C. L., Vigne, J., Hecht, N. B., & Brake, P. B. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0355 · Cited by 16
Self-citation
Metadata
- Authors
- Pandey, A. V., Mellon, S. H., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Miller, Walter L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 278
- Issue
- 5
- Pages
- 2837-2844
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2073701436
- Semantic Scholar
- d9bb02d813f717d420942451c3554cd90c8ded53
- Cited by
- 137
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 3 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 3
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6498 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34449, HD27970, HD-41958, R01HD027970, U54HD034449, R01HD041958)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- protein phosphatase 2A, P450c17, 17,20-lyase activity, androgen production, serine phosphorylation, post-translational regulation, adrenal cortex, adrenarche, polycystic ovary syndrome, okadaic acid, fostriecin, cantharidin
- MeSH terms
- Adrenal Cortex Neoplasms, Androgens, Base Sequence, Chromosomal Proteins, Non-Histone, DNA-Binding Proteins, Enzyme Inhibitors, Humans, Hydroxylation, Kinetics, Microsomes, Phosphoprotein Phosphatases, Phosphorylation, Phosphoserine, Proteins, Recombinant Proteins, Steroid 17-alpha-Hydroxylase, Transcription Factors, Tumor Cells, Cultured, DNA Primers, Okadaic Acid, Reverse Transcriptase Polymerase Chain Reaction, Protein Phosphatase 2, Histone Chaperones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.